Author:
Matsuo Yukinori,Hanazawa Hideki,Kishi Noriko,Ueki Kazuhito,Mizowaki Takashi
Publisher
Springer Berlin Heidelberg
Reference110 articles.
1. Agolli L, Valeriani M, Carnevale A, Falco T, Bracci S, De SV et al (2015) Role of salvage stereotactic body radiation therapy in post-surgical loco-regional recurrence in a selected population of non-small cell lung cancer patients. Anticancer Res 35:1783–1789
2. Badiyan SN, Rutenberg MS, Hoppe BS, Mohindra P, Larson G, Hartsell WF et al (2019) Clinical outcomes of patients with recurrent lung cancer reirradiated with proton therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies. Pract Radiat Oncol 9(4):280–288. https://doi.org/10.1016/j.prro.2019.02.008
3. Bae SH, Ahn YC, Nam H, Park HC, Pyo HR, Shim YM et al (2012) High dose involved field radiation therapy as salvage for loco-regional recurrence of non-small cell lung cancer. Yonsei Med J 53(6):1120. https://doi.org/10.3349/ymj.2012.53.6.1120
4. Ball D, Mai GT, Vinod S, Babington S, Ruben J, Kron T et al (2019) Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3 open-label, randomised controlled trial. Lancet Oncol 20(4):494–503. https://doi.org/10.1016/S1470-2045(18)30896-9
5. Bedwinek J, Petty A, Bruton C, Sofield J, Lee L (1992) The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 22(1):23–30. http://www.ncbi.nlm.nih.gov/pubmed/1727125